Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures rose on Wednesday tracking further progress toward a bumper coronavirus stimulus package, while markets hoped for an affirmation of continued easy monetary policy from the Federal Reserve’s last meeting for the year. .N
At 6:46 a.m. ET, Dow e-minis 1YMc1 were up 0.30% at 30,295. S&P 500 e-minis ESc1 were up 0.29% at 3,705.25, while Nasdaq 100 e-minis NQc1 were up 0.23% at 12,620.25. The top three NYSE percentage gainers premarket .PRPG.NQ: ** Drive Shack Inc <DS.N>, up 14.3 % ** R. R. Donnelley & Sons Company <RRD.N>, up 9.1 % ** Safe Bulkers Inc <SB.N>, up 6.9 % The top three NYSE percentage losers premarket .PRPL.NQ: ** Concord Medical Services Holdings <CCM.N>, down 34.5 % ** Penumbra Inc <PEN.N>, down 10.5 % ** Apartment and Investment Management Co <AIV.N>, down 6.7 % The top three Nasdaq percentage gainers premarket .PRPG.O: ** Neovasc Inc <NVCN.O>, up 70.5 % ** Sio Gene Therapies Inc <SIOX.O>, up 45.1 % ** Good Times Restaurants Inc <GTIM.O>, up 30.3 % The top three Nasdaq percentage losers premarket .PRPL.O: ** Vtv Therapeutics Inc <VTVT.O>, down 27.9 % ** Endra Life Sciences Inc <NDRA.O>, down 17.8 % ** SPAR Group Inc <SGRP.O>, down 17.2 % ** Castle Biosciences CSTL.O: down 3.4% premarket BUZZ-Falls on $232 mln discounted share offer ** BioNTech BNTX.O: up 3.4% premarket BUZZ-Rises as China’s Fosun Pharma to buy 100 mln COVID-19 vaccine doses
** ENDRA Life Sciences NDRA.O: down 17.8% premarket BUZZ-Down on share offering ** Sio Gene SIOX.O: up 45.1% premarket BUZZ-Surges on positive follow-up data from gene therapy study ** Tilray Inc TLRY.O: up 21.5% premarket BUZZ-Pot producers jump on report of merger deal ** Cellectis CLLS.O: up 11.2% premarket BUZZ-Bounces after co pulls equity offering ** Aurora Mobile Ltd JG.O: up 0.3% premarket BUZZ-Rises on WM Motor partnership
(Compiled by Rithika Krishna)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.